In this study, we showed that YBX1 could promote glycolysis in bladder cancer cells by modulating Myc and HIF1α expression, which further facilitate the expression of glycolytic enzymes and ultimately contribute to tumor progression. The gene discussed is HIF1A; the disease is urinary bladder carcinoma.